About this trial
This study evaluates the diagnostic yield of invasive genetic testing in fetuses with isolated intrauterine growth restriction diagnosed after 28 weeks of gestation, in order to better define indications for invasive procedures and improve clinical counseling.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Maternal age ≥ 18 years
Referral after 28 weeks of gestation for estimated fetal weight < 3rd percentile, isolated condition
Management at Strasbourg University Hospitals between 01/01/2016 and 01/01/2023
No documented opposition to reuse of medical data for research
Disqualifiers
Suspected fetal structural anomaly or infectious cause
Multiple pregnancy
Incomplete genetic workup
Trial population
Pregnant women managed at Strasbourg University Hospitals with isolated intrauterine growth restriction diagnosed after 28 weeks of gestation between 2016 and 2023.
Trial design
Case-only
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Diagnostic yield of invasive genetic testing in isolated IUGR
Proportion of invasive prenatal procedures identifying a genetic abnormality explaining the intrauterine growth restriction
Sponsors and contacts
Click on the lead sponsor to view all of their trials.